12 Partners (4 research institutes, 3 SMEs and 5 cancer clinics) from 6 different European and associated countries.
Azienda Ospedaliero Universitaria di Parma
AOP is coordinating the project and leads the clinical and scientific research for prospective studies.
Universidad Politecnica de Madrid
UPM is the Technical Coordinator and leads the semantic framework and the overall BD2Decide design.
Stichting VU University Medical Center
VUMC is responsible for the design of the clinical study and the prediction modelling.
UDUS contributes to the clinical studies with patients' data for validation of the project research.
Fondazione IRCCS Istituto Nazionale dei Tumori
INT leads the clinical research in genomics, the genomics data collection and data analysis.
Fraunhofer IGD Visual Computing
Fraunhofer offers solutions for tumor segmentation and image features extraction.
Athens Technology Center S.A.
ATC leads the patients' data visualization and virtual representation tools.
All in Image Ltd
All-in-Image leads the Big Data Infrastructure and the integration of population and other data for analysis.
MAASTRICHT RADIATION ONCOLOGY MAASTRO
MAASTRO leads the CT scan radiomics task and participates in the clinical study.
Politecnico di Milano
POLIMI leads the MRI scan radiomics task and the identification of radiomics signatures from MRI and DWI-MRI scans.
MultiMed Engineers Srls
MME coordinates the exploitation and communication strategy and the actions for maximizing project impact.
Università degli Studi di Parma
Unipr contributes to the clinical study setup and execution and the validation of the project results.